Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma
PaperCitations, authors & open-access status
Low-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 0 citations, 2022 year and diamond oa status.
0
Citations
2022
Year
diamond
OA Status